Literature DB >> 24477718

Acute and chronic ataxic neuropathies with disialosyl antibodies: a continuous clinical spectrum and a common pathophysiological mechanism.

Nobuhiro Yuki1, Antonino Uncini.   

Abstract

Acute ataxic neuropathies with disialosyl antibodies include Fisher syndrome, ataxic Guillain-Barré syndrome (GBS), and acute sensory ataxic neuropathy. Fisher syndrome and ataxic GBS are more strongly associated with IgG anti-GQ1b and anti-GT1a than with anti-GD1b antibodies, whereas the association is reversed in the case of acute sensory ataxic neuropathy. Chronic ataxic neuropathy with disialosyl antibodies is associated with IgM paraprotein to GD1b and GQ1b, which occasionally reacts with GT1a. The clinical, electrophysiological, and pathological features, along with experimental findings, suggest that acute and chronic ataxic neuropathies with disialosyl antibodies form a continuous clinical and pathophysiological spectrum characterized by a complement-mediated disruption at the nodal region and are better classified in the new category of nodo-paranodopathies.
Copyright © 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Fisher syndrome; Guillain-Barré syndrome; anti-GD1b antibody; anti-GQ1b antibody; ataxic neuropathy

Mesh:

Substances:

Year:  2014        PMID: 24477718     DOI: 10.1002/mus.24192

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  13 in total

1.  Taste impairment in Miller Fisher syndrome.

Authors:  Yohsuke Yagi; Hiroaki Yokote; Yukiko Watanabe; Takeshi Amino; Tomoyuki Kamata; Susumu Kusunoki
Journal:  Neurol Sci       Date:  2014-08-13       Impact factor: 3.307

Review 2.  Sustained response to subcutaneous immunoglobulins in chronic ataxic neuropathy with anti-disialosyl IgM antibodies (CANDA): report of two cases and review of the literature.

Authors:  D Marastoni; L Africa; G M Fabrizi; F Giannini; A Peretti; S Bocci; L Insana; S Ferrari; F Ginanneschi; G Zanette
Journal:  J Neurol       Date:  2020-04-28       Impact factor: 4.849

3.  Acute comitant strabismus in anti-GQ1b antibody syndrome.

Authors:  Sun-Uk Lee; Seol-Hee Baek; Hyo-Jung Kim; Jeong-Yoon Choi; Byung-Jo Kim; Ji-Soo Kim
Journal:  J Neurol       Date:  2022-09-29       Impact factor: 6.682

Review 4.  The ataxic neuropathies.

Authors:  Stéphane Mathis; Fanny Duval; Antoine Soulages; Guilhem Solé; Gwendal Le Masson
Journal:  J Neurol       Date:  2020-06-15       Impact factor: 4.849

5.  Monoclonal gammopathies of clinical significance.

Authors:  Angela Dispenzieri
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

6.  Sensory Ataxic Guillain-Barré Syndrome with Dysgeusia after mRNA COVID-19 Vaccination.

Authors:  Shunsuke Ogata; Yoshito Ishii; Keiichiro Asano; Erena Kobayashi; Shun Kubota; Keita Takahashi; Yosuke Miyaji; Yuichi Higashiyama; Hideto Joki; Hiroshi Doi; Michiaki Koga; Hideyuki Takeuchi; Fumiaki Tanaka
Journal:  Intern Med       Date:  2022-03-26       Impact factor: 1.282

Review 7.  Diagnosis and management of monoclonal gammopathy of clinical significance.

Authors:  Hyungwoo Cho
Journal:  Blood Res       Date:  2022-04-30

8.  Facial Involuntary Movements and Respiratory Failure in CANOMAD, Responsive to IVIG Therapy.

Authors:  Kate Johnson; Ashish Malkan; Mohamed Shaffi
Journal:  Case Rep Med       Date:  2015-11-30

Review 9.  Guillain-Barré and Miller Fisher syndromes--new diagnostic classification.

Authors:  Benjamin R Wakerley; Antonino Uncini; Nobuhiro Yuki
Journal:  Nat Rev Neurol       Date:  2014-07-29       Impact factor: 42.937

Review 10.  Neuroinflammation in the peripheral nerve: Cause, modulator, or bystander in peripheral neuropathies?

Authors:  Rudolf Martini; Hugh Willison
Journal:  Glia       Date:  2015-08-06       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.